The aim of this study was to explore proximal fluid and ovarian cyst fluid as a source for early biomarkers and also to identify potential inflammatory biomarkers that could improve the sensitivity of CA125 in early diagnosis of ovarian cancer. This evidence concerns the gene MUC16 and Ovarian cyst.